Minerva Rogers

Minerva Rogers currently serves as the Chief Safety Officer (CSO) and a dedicated Health Fraud Investigator within the FDA’s Office of Inspections & Investigations. In this pivotal role, she oversees and conducts complex online investigations aimed at identifying and mitigating fraudulent activities related to FDA-regulated products, including dietary supplements, pharmaceuticals, and medical devices. Minerva’s expertise lies in leveraging advanced fraud detection techniques and digital intelligence tools to uncover high-risk threats that could compromise public health. Her work involves meticulous background research on individuals and entities suspected of engaging in deceptive practices, ensuring that regulatory actions are grounded in thorough, evidence-based analysis.

Throughout her tenure, Minerva has led numerous high-stakes investigations into violations of the Federal Food, Drug, and Cosmetic (FD&C) Act, often focusing on products that pose significant safety concerns or violate labeling and marketing regulations. Her deep understanding of regulatory requirements, combined with her proficiency in medical imaging, quality systems, and drug development, enables her to evaluate complex cases involving medical devices and pharmaceuticals. She collaborates closely with multidisciplinary teams to develop strategic enforcement actions, including product recalls, warning letters, and criminal investigations.

Minerva’s role also involves continuous engagement with industry stakeholders and law enforcement partners to enhance fraud detection methodologies and promote compliance. Her skills in interpersonal communication and her comprehensive knowledge of technology transfer and R&D processes position her as a vital asset in safeguarding the integrity of the supply chain and protecting consumers from fraudulent or unsafe products. Her dedication to public health and her analytical acumen make her a key leader in the FDA’s ongoing efforts to combat health fraud and ensure the safety of FDA-regulated products.